STUDY PROTOCOL FOR AN AQUACULTURE INVESTIGATIONAL NEW ANIMAL DRUG (INAD) EXEMPTION FOR THE USE OF 17-ALPHA METHYLTESTOSTERONE IN TILAPIA (INAD #11-236)

Document - application/pdf
STUDY PROTOCOL FOR AN AQUACULTURE INVESTIGATIONAL NEW ANIMAL DRUG (INAD) EXEMPTION FOR THE USE OF 17-ALPHA METHYLTESTOSTERONE IN TILAPIA (INAD #11-236)

17α-methyltestosterone (MET) is an aquaculture premix and is only available through Rangen Inc. The primary goal of studies conducted under INAD #11-236 is to generate data evaluating the efficacy of MET administered in feed to larval tilapia to produce populations comprised of >90% male fish. 

Attachments
AttachmentSize
MT-study-protocol-2021.pdf608.73 KB608.73 KB
Author(s)
Publication date
Type of document
Protocol
Program
Juvenile Northern Pike in aquarium at Gavins Point National Fish Hatchery, South Dakota
The Fish and Aquatic Conservation program leads aquatic conservation efforts for the U.S. Fish and Wildlife Service. We are committed to tackling the nation’s highest priority aquatic conservation and recreational challenges to conserve, restore, and enhance fisheries for future generations.
A fish with a reddish tone body with black spots on upper part of body, this side view of a Chinook salmon shows the salmon swimming right above a gravel riverbed.
Healthy fisheries are core to the conservation work of the U.S. Fish and Wildlife Service. We are working with partners to protect and enhance the health of fish and other aquatic animals in aquaculture and in the wild.